Minute Insight: FDA Approves Abbott’s SCS For Non-Surgical Back Pain
Executive Summary
The approval, supported by the results of the randomized DISTINCT trial, includes all of Abbott’s spinal cord stimulation devices that deliver the proprietary BurstDR waveform.